BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 14 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 14 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 14 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 15 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 15 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 16 hours ago Atmus Welcomes Heath Sharp to Board of Directors 18 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 18 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 14 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 14 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 14 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 15 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 15 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 16 hours ago Atmus Welcomes Heath Sharp to Board of Directors 18 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 18 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

AbbVie (ABBV) Earnings: Key financials and quarterly highlights

AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021. Net revenues increased 34% to $13.9 billion. Net income for the first quarter was $766 million, or $0.42 per share, compared to the net loss of $738 million, or $0.46 per share in the second quarter of 2020

$ABBV July 30, 2021 1 min read

AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021.

Net revenues increased 34% to $13.9 billion.

Net income for the first quarter was $766 million, or $0.42 per share, compared to the net loss of $738 million, or $0.46 per share in the second quarter of 2020

ADVERTISEMENT
ADVERTISEMENT